home > news & events > news
News
January 5, 2010 - Trading Update
Cyprotex PLC ("Cyprotex" or "the Company" or "the Group")
Cyprotex (LSE:CRX), the drug discovery technology and information company, notes yesterday's fall in the share price and is unaware of any reason for this share price movement. The Company re-iterates that its current trading is in line with market expectations following its trading update of 20 November 2009.
The Company expects to release a trading update towards the end of January 2010, in respect of calendar year ended 31 December 2009.
For further information:
Cyprotex PLC
Dr Anthony Baxter, Chief Executive Officer
John Dootson, Chief Financial Officer
Tel: +44 (0) 1625 505 100
Noble & Company
John Llewellyn-Lloyd
Tel: +44 (0) 20 7763 2200
john.llewellyn-lloyd@noblegp.com
Financial Dynamics
Ben Brewerton / Ben Atwell / John Dineen
Tel: +44 (0) 20 7831 3113
| 2009 archive | + | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||||||||||||||||||||||
| 2008 archive | + | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||
| 2007 archive | + | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
| 2006 archive | + | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
| 2005 archive | + | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
| 2004 archive | + | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
| 2003 archive | + | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||
| 2002 archive | + | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Contact us for more information on Cyprotex Discovery, including our extensive range of ADMET/PK services
and pricing.
